Remedy Entertainment Oyj (REMEDY.HE)
EUR 13.5
(0.0%)
EUR 13.5
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -16.03 Million | 11.06 Million | 5.18 Million | 11.8 Million | -492.38 Thousand | 2.39 Million |
| Net Income | -22.65 Million | -1.72 Million | 8.79 Million | 10.33 Million | 5.23 Million | 532.16 Thousand |
| Depreciation & Amortization | 11.67 Million | 2.46 Million | 2.07 Million | 1.06 Million | 821.91 Thousand | 492.7 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 2.68 Million | 3.6 Million | 2.45 Million | - | - | - |
| Change in working capital | - | - | - | - | - | -1.06 Million |
| Other non-cash items | -7.73 Million | 6.72 Million | -8.14 Million | 401.37 Thousand | -6.55 Million | 2.93 Million |
| Investing Cash Flow | -9.82 Million | -10.62 Million | -16.6 Million | -6.34 Million | -2.46 Million | -3 Million |
| Investments in PPE | -7.06 Million | -10.65 Million | -12.6 Million | -6.34 Million | -2.46 Million | -3 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -2.75 Million | - | -4 Million | - | - | - |
| Sales/Maturities of investments | - | 34 Thousand | - | - | - | - |
| Other Investing Activities | -7.53 Million | -8.11 Million | -15.48 Million | - | -2.46 Million | -3 Million |
| Financing Cash Flow | -3.11 Million | -2.79 Million | 39.11 Million | -1.32 Million | -518.03 Thousand | 1.05 Million |
| Debt repayment | -919 Thousand | -919 Thousand | -918.5 Thousand | -6847.80 | -689.18 Thousand | -1.04 Million |
| Dividends payments | -1.34 Million | -2.26 Million | -1.96 Million | -1.32 Million | -1.2 Million | - |
| Common Stock Repurchased | - | - | -0.10 | - | - | - |
| Common Stock Issuance | 462 Thousand | 1.35 Million | 41.99 Million | - | - | - |
| Other Financing Activities | -1.3 Million | -968 Thousand | 2054.60 | 13.69 Thousand | 1.37 Million | 1.05 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 49.03 Million | 51.38 Million | 23.68 Million | 19.55 Million | 23.02 Million | 22.58 Million |
| Cash at end of period | 20.06 Million | 49.03 Million | 51.38 Million | 23.68 Million | 19.55 Million | 23.02 Million |
| Capital Expenditure | -7.06 Million | -10.65 Million | -12.6 Million | -6.34 Million | -2.46 Million | -3 Million |
| Effect of forex changes on cash | -1.00 | - | -478.12 | 0.78 | - | - |
| Net cash flow / Change in cash | -28.96 Million | -2.35 Million | 27.69 Million | 4.13 Million | -3.47 Million | 439.39 Thousand |
| Free Cash Flow | -23.09 Million | 412 Thousand | -7.41 Million | 5.46 Million | -2.95 Million | -611.26 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.21 Million | -2.1 Million | -22.65 Million | -14.35 Million | -7.17 Million | -8.3 Million |
| Depreciation & Amortization | 374 Thousand | 374 Thousand | 11.67 Million | 10.21 Million | 1.04 Million | 1.45 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 2.68 Million | 1.34 Million | 1.34 Million | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 3.93 Million | 3.82 Million | -7.73 Million | 19.5 Million | 2.25 Million | -1.2 Million |
| Investing Cash Flow | -995 Thousand | -995 Thousand | -9.82 Million | -2.33 Million | -1.16 Million | -7.48 Million |
| Investments in PPE | -11.5 Million | -11.5 Million | -7.06 Million | 858 Thousand | 858 Thousand | -2 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -2.75 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 10.5 Million | 10.5 Million | -7.53 Million | -2.02 Million | -2.02 Million | -1.74 Million |
| Financing Cash Flow | 61 Thousand | 61 Thousand | -3.11 Million | -1.41 Million | -705.5 Thousand | -1.7 Million |
| Debt repayment | - | - | -919 Thousand | - | - | - |
| Dividends payments | - | - | -1.34 Million | -673.5 Thousand | -673.5 Thousand | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 462 Thousand | - | - | - |
| Other Financing Activities | 61 Thousand | 61 Thousand | -1.3 Million | -32 Thousand | -32 Thousand | -850.5 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 20.06 Million | - | 49.03 Million | 28.87 Million | - | 49.03 Million |
| Cash at end of period | 22.37 Million | 1.15 Million | 20.06 Million | 20.06 Million | -4.4 Million | 28.87 Million |
| Capital Expenditure | -11.5 Million | -11.5 Million | -7.06 Million | 858 Thousand | 858 Thousand | -2 Million |
| Effect of forex changes on cash | - | - | -1.00 | - | - | - |
| Net cash flow / Change in cash | 2.3 Million | 1.15 Million | -28.96 Million | -8.81 Million | -4.4 Million | -20.15 Million |
| Free Cash Flow | -9.41 Million | -9.41 Million | -23.09 Million | -4.2 Million | -1.67 Million | -12.97 Million |
036630
BIOIF
ANRG
PLTK
ALTRI
ECOM